EVs treatment inhibited the expression of TLR-2 and TLR-4 genes in LPS stimulated LX-2 cells; EVs inhibited the activation of HSC in HFD and CCl4 induced liver fibrosis mice and significantly reduced the expression of fibrosis and inflammation biomarkers in mouse tissues. The gene discussed is TLR2; the disease is Hepatic fibrosis.